PVLA – palvella therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Palvella Therapeutics Announces Pricing of Upsized Public Offering
Palvella Therapeutics (PVLA) had its price target raised by Mizuho from $205.00 to $250.00. They now have an "outperform" rating on the stock.
Palvella Therapeutics (PVLA) had its price target raised by BTIG Research from $192.00 to $215.00. They now have a "buy" rating on the stock.
Palvella Therapeutics (PVLA) was given a new $210.00 price target by Truist Financial Corporation.
Form 4 PALVELLA THERAPEUTICS, For: Feb 27 Filed by: JENKINS GEORGE M
Form 4 PALVELLA THERAPEUTICS, For: Feb 27 Filed by: HERON ELAINE J
Form 8-K PALVELLA THERAPEUTICS, For: Feb 25
Form 424B5 PALVELLA THERAPEUTICS,
Form 424B5 PALVELLA THERAPEUTICS,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.